Detection of human cytomegalovirus in bronchoalveolar lavage of intensive care unit patients

Autor/a

Vergara, Andrea

Cillóniz, Catia

Luque Chipana, Néstor Alejandro

Garcia Vidal, Carolina

Tejero Salvador, Xavier

Perelló, Rafael

Lucena, Carmen M.

Torres Martí, Antoni

Marcos, Ma. Angeles

Fecha de publicación

2019-11-12T10:04:49Z

2020-07-01T05:10:31Z

2018

2019-11-12T10:04:49Z

Resumen

The seroprevalence of human cytomegalovirus (CMV) is very high worldwide [1, 2] and the spectrum of disease caused by it ranges from an asymptomatic state to a mononucleosis-like syndrome to severe diseases such as pneumonia, retinitis or gastrointestinal infection. The most severe disease occurs in congenital infection and in immunosuppressed patients, in whom the virus acts as an opportunistic pathogen. However, the role of CMV in other populations is less clear and is controversial [3]. Some studies in critical patients describe a relationship between CMV and increased mortality rates, longer length of stay and prolonged need for mechanical ventilation [3-5]. The incidence of active CMV infection depends on the diagnostic method used. Several epidemiological studies and systematic reviews have assessed the incidence of CMV infection in mechanically ventilated, critically ill patients, finding values ranging from 0-36% [5-7]. In this study, we aimed to assess the incidence, clinical characteristics, risk factors and outcomes for intensive care unit (ICU) patients with CMV detection by bronchoalveolar lavage (BAL).

Tipo de documento

Artículo
Versión aceptada

Lengua

Inglés

Materias y palabras clave

Citomegalovirus; Unitats de cures intensives; Cytomegaloviruses; Intensive care units

Publicado por

European Respiratory Society

Documentos relacionados

Versió postprint del document publicat a: https://doi.org/10.1183/13993003.01332-2017

European Respiratory Journal, 2018, vol. 51, num. 2, p. 1701332

https://doi.org/10.1183/13993003.01332-2017

Derechos

(c) European Respiratory Society, 2018